Tampal, Ponciano T.
HRN: 01-89-81 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/01/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/01/2023
10/08/2023
IV
1.5g
Q6hrs
Multiple Lacerated Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes